Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
NCT04615065 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 35000
Last updated 2024-06-13
Summary
Research in acute care faces many challenges, including enrollment challenges, legal limitations in data sharing, limited funding, and lack of singular ownership of the domain of acute care. To overcome some of these challenges, the Center of Acute Care of the University Medical Center Groningen in the Netherlands, has established a de novo data-, image- and biobank named "Acutelines". Acutelines is initiated to improve recognition and treatment of acute diseases and obtain insight in the consequences of acute diseases, including factors predicting its outcome. Thereby, Acutelines contributes to development of personalized treatment and improves prediction of patient outcomes after an acute admission.
Conditions
- Acute Disease
- Sepsis
- Pneumonia
- Frailty
- Complication of Treatment
- Pulmonary Embolism
- Thrombosis
- Acute Kidney Injury
- Electrolyte Disturbance
- Hemorrhage
- Shock
- Polypharmacy
- Intoxication by Drug
- Emergencies
- Urinary Tract Infections
- Skin Infection
- Syncope
- Anaphylaxis
- Dyspnea
Sponsors & Collaborators
-
University Medical Center Groningen
lead OTHER
Principal Investigators
-
Ewoud ter Avest, MD, PhD · University Medical Center Groningen
-
Jan ter Maaten, MD, PhD · University Medical Center Groningen
-
Hjalmar Bouma, MD, PhD · University Medical Center Groningen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2030-09-01
- Completion
- 2030-09-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy
NCT00634491 ·Status: COMPLETED ·Phase: PHASE2
-
L-citrulline Supplementation During Sepsis
NCT00628381 ·Status: UNKNOWN ·Phase: PHASE3
-
Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography
NCT01144091 ·Status: WITHDRAWN ·Phase: NA
-
Aminophylline and Contrast Induced Nephropathy in Acute Myocardial Infarction
NCT01594489 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI
NCT06286059 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Effect of Dexmedetomidine on Kidney Function in EVAR
NCT04766047 ·Status: UNKNOWN ·Phase: NA
-
Sympathetic Nerve Activity in Renal Failure
NCT00892892 ·Status: WITHDRAWN ·Phase: PHASE4
-
Prevention of Serious Adverse Events Following Angiography
NCT01467466 ·Status: COMPLETED ·Phase: PHASE3
-
Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography
NCT02463604 ·Status: COMPLETED ·Phase: NA
-
Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease
NCT04163484 ·Status: COMPLETED
-
The CHYMASE Angiotensin-(1-12) Axis in Cardiovascular Disease
NCT03826745 ·Status: UNKNOWN
-
Study of CXA-10 in Healthy Volunteers
NCT02127190 ·Status: COMPLETED ·Phase: PHASE1
-
The Acetylcysteine for Contrast-Induced Nephropathy Trial
NCT00736866 ·Status: COMPLETED ·Phase: PHASE3
-
Using Preprocedural Urine NMR(Nuclear Magnetic Resonance) -Based Metabolomics Analysis
NCT03731962 ·Status: COMPLETED ·Phase: NA
-
Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
NCT00575419 ·Status: TERMINATED ·Phase: PHASE1
-
A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia
NCT00614679 ·Status: COMPLETED ·Phase: PHASE1
-
Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
NCT02651428 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Nephrotoxicity Amelioration by N-acetylcysteine
NCT06122311 ·Status: COMPLETED ·Phase: NA
-
The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
NCT00498342 ·Status: COMPLETED ·Phase: NA
-
N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome
NCT03346681 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients
NCT00885300 ·Status: COMPLETED ·Phase: NA
-
Methylene Blue for the Prevention of Hypotension During Hemodialysis
NCT05092165 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Sublingually Generated S-nitroso-N-acetylcysteine on Systemic Blood Pressure.
NCT05798481 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
NCT01218178 ·Status: COMPLETED
-
N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography
NCT00830193 ·Status: COMPLETED ·Phase: PHASE2/PHASE3